×
About 32,610 results

ALLMedicine™ Fatty Liver Center

Research & Reviews  11,099 results

Pemvidutide promising for fatty liver disease
https://www.mdedge.com/internalmedicine/article/255866/gastroenterology/pemvidutide-promising-fatty-liver-disease
Sara Freeman

Jun 29th, 2022 - LONDON – Weight loss, lipid reductions, and “robust improvements” in lipid species associated with nonalcoholic fatty liver disease were achieved in patients who were treated with pemvidutide in a first-in-human, phase 1 clinical trial reported at.

Intrahepatic triglyceride content: influence of metabolic and genetics drivers.
https://doi.org/10.1097/MCO.0000000000000838 10.1017/S0029665121003761 10.1002/hep.32427 10.1136/bmjdrc-2019-000871 10.1172/jci.insight.144079
Current Opinion in Clinical Nutrition and Metabolic Care; Dearlove DJ, Hodson L

Jun 29th, 2022 - Intrahepatic triglyceride (IHTG) content is determined by substrate flux to, fatty acid synthesis and partitioning within, and triglyceride disposal from the liver. Dysregulation of these processes may cause IHTG accumulation, potentially leading ...

Thyroid stimulating hormone levels are associated with genetically predicted nonalcohol...
https://doi.org/10.1210/clinem/dgac393
The Journal of Clinical Endocrinology and Metabolism; Fan H, Liu Z et. al.

Jun 29th, 2022 - Findings of observational studies indicated an association of thyroid hormone levels with the risk of nonalcoholic fatty liver disease (NAFLD), whereas conflicting results remained and might be subject to reverse causality. This study aimed to eva...

Therapeutic Potential of Artichoke in the Treatment of Fatty Liver: A Systematic Review...
https://doi.org/10.1089/jmf.2022.0025
Journal of Medicinal Food; Kamel AM, Farag MA

Jun 29th, 2022 - Nonalcoholic fatty liver disease (NAFLD) is a major chronic liver disease that can lead to liver cirrhosis, liver cancer, and death. Artichoke leaf extract (ALE) is well known in folk medicine for its hepatoprotective effect. Till recent times, no...

Slightly different metabolomic profiles are associated with high or low weight duck foi...
https://doi.org/10.1371/journal.pone.0255707
PloS One; Lo B, Marty-Gasset N et. al.

Jun 29th, 2022 - Understanding the evolution of fatty liver metabolism of ducks is a recurrent issue for researchers and industry. Indeed, the increase in weight during the overfeeding period leads to an important change in the liver metabolism. However, liver wei...

see more →

Guidelines  22 results

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diag...
https://doi.org/10.1016/j.eprac.2022.03.010
Endocrine Practice : Official Journal of the American Col... Cusi K, Isaacs S et. al.

May 16th, 2022 - To provide evidence-based recommendations regarding the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) to endocrinologists, primary care clinicians, health care professionals, and other...

Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the ...
https://doi.org/10.1016/j.numecd.2021.04.028
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; , et. al.

Dec 21st, 2021 - Nonalcoholic fatty liver disease (NAFLD) is a common and emerging liver disease in adults, paralleling the epidemic of obesity and diabetes, and leading to worrisome events (hepatocellular carcinoma and end-stage liver disease). In the last years,...

Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123074
Eating and Weight Disorders : EWD;

Dec 17th, 2021 - Nonalcoholic fatty liver disease (NAFLD) is a common and emerging liver disease in adults, paralleling the epidemic of obesity and diabetes and leading to worrisome events (hepatocellular carcinoma and end-stage liver disease). In the past years, ...

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonal...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819923
Gastroenterology Kanwal F, Shubrook JH et. al.

Oct 5th, 2021 - Find AGA's NASH Clinical Care Pathway App for iOS and Android mobile devices at nash.gastro.org. Scan this QR code to be taken directly to the website.Nonalcoholic fatty liver disease (NAFLD) is becoming increasingly common, currently affecting ap...

Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recomm...
https://doi.org/10.1001/jama.2021.12531
JAMA , Davidson KW et. al.

Aug 25th, 2021 - An estimated 13% of all US adults (18 years or older) have diabetes, and 34.5% meet criteria for prediabetes. The prevalences of prediabetes and diabetes are higher in older adults. Estimates of the risk of progression from prediabetes to diabetes...

see more →

Drugs  14 results see all →

Clinicaltrials.gov  915 results

Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease
https://clinicaltrials.gov/ct2/show/NCT02520609

Jun 24th, 2022 - Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic disorder in the Western world, and is a leading cause of liver-related morbidity and mortality. Excessive caloric intake and specific nutritional components have been implicated ...

Metabolic Pathology of Pediatric NAFLD
https://clinicaltrials.gov/ct2/show/NCT05430178

Jun 24th, 2022 - This project uses a cross-sectional design with a single testing period without an intervention or follow-up period. Participants with nonalcoholic fatty liver disease (NAFLD), and age-matched control groups classified as either obese (Ob control)...

Genetic Studies of Insulin and Diabetes
https://clinicaltrials.gov/ct2/show/NCT00001987

Jun 24th, 2022 - Study Description: Insulin is the key hormone responsible for regulating the level of glucose in plasma. In several disease states (e.g., obesity, type 2 diabetes, and acromegaly), the target cells are resistant to insulin action. Insulin resistan...

Nonalcoholic Fatty Liver Disease in HIV Database
https://clinicaltrials.gov/ct2/show/NCT05023044

Jun 24th, 2022 - NAFLD is the most prevalent of all liver disorders and is the most common cause of chronic aminotransferase elevations in the U.S. With the availability of highly effective ART, chronic liver disease has become a leading cause of non-AIDS related ...

Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
https://clinicaltrials.gov/ct2/show/NCT03884075

Jun 24th, 2022 - Non-alcoholic fatty liver disease (NAFLD) and its progressive form, non-alcoholic steatohepatitis (NASH), are leading causes of liver injury and are tightly associated with obesity, diabetes and the metabolic syndrome. Despite recent advances, the...

see more →

News  979 results

Pemvidutide promising for fatty liver disease
https://www.mdedge.com/internalmedicine/article/255866/gastroenterology/pemvidutide-promising-fatty-liver-disease
Sara Freeman

Jun 29th, 2022 - LONDON – Weight loss, lipid reductions, and “robust improvements” in lipid species associated with nonalcoholic fatty liver disease were achieved in patients who were treated with pemvidutide in a first-in-human, phase 1 clinical trial reported at.

Fatty Liver Disease Drives Rise in Liver Cancer Deaths
https://www.medscape.com/viewarticle/976213

Jun 27th, 2022 - LONDON ― Around the world, nonalcoholic fatty liver disease (NAFLD) has driven an increase in deaths from liver cancer over the past decade, overtaking alcoholic liver disease, hepatitis B, and hepatitis C, according to an analysis of the Global B...

Low-Carb, High-Fat Diet Improves A1c, Reduces Liver Fat: Study
https://www.medscape.com/viewarticle/976209

Jun 27th, 2022 - LONDON — A low-carbohydrate, high-fat (LCHF) diet reduced the progression of nonalcoholic fatty liver disease (NAFLD), and despite no calorie restriction, participants with both NAFLD and type 2 diabetes lost 5.8% of their body weight, according t...

NAFLD significantly increases the risk for HCC
https://www.mdedge.com/fedprac/article/255704/hepatocellular-carcinoma/nafld-significantly-increases-risk-hcc

Jun 23rd, 2022 - Key clinical point: Nonalcoholic fatty liver disease (NAFLD) is independently associated with an increased risk for hepatocellular carcinoma (HCC). Major finding: NAFLD significantly increased the risk for HCC (hazard ratio [HR] 1.

Alcoholic Cirrhosis Is Most Common Liver Transplant Indication in Young US Adults
https://www.medscape.com/viewarticle/975925

Jun 22nd, 2022 - NEW YORK (Reuters Health) - Alcohol-associated liver disease is now the most common indication for liver transplant wait-listing among young American adults, researchers say. From 2003 to 2018, the diagnosis of alcoholic liver disease (ALD) as an ...

see more →

Patient Education  15 results see all →